For example, a novel dual agonist of GLP-1/GIP receptors significantly increased BDNF levels in a mouse model of Parkinsons disease, induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration [53]
Expert Swaps: Cerebrolysin is a brain recovery peptide that has shown promise in staving off neurodegenerative diseases like Alzheimers (18)
M., Croce, K
Researchers estimate that, at this rate, people would return to their starting weight within 1.5 to 2 years
By enhancing insulin function, reducing inflammation, and stabilizing glucose levels, GLP-1 antagonists may support long-term weight management and lower the risk of metabolic diseases like Type 2 diabetes and heart disease
However, once you achieve your goal, you and your provider may discuss tapering off the medication